(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202306 | 202206 | % Var | 202306 | 202206 | % Var | 202303 | 202203 | % Var | |
| Sales | 34956.40 | 27324.90 | 27.93 | 34956.40 | 27324.90 | 27.93 | 112588.30 | 117716.70 | -4.36 |
| Other Income | 277.40 | 64.80 | 328.09 | 277.40 | 64.80 | 328.09 | 912.60 | 1504.20 | -39.33 |
| PBIDT | 7327.60 | 2951.80 | 148.24 | 7327.60 | 2951.80 | 148.24 | 11739.20 | 4261.30 | 175.48 |
| Interest | 161.80 | 198.70 | -18.57 | 161.80 | 198.70 | -18.57 | 984.40 | 734.70 | 33.99 |
| PBDT | 7165.80 | 2753.10 | 160.28 | 7165.80 | 2753.10 | 160.28 | 10754.80 | 3526.60 | 204.96 |
| Depreciation | 1400.50 | 1303.50 | 7.44 | 1400.50 | 1303.50 | 7.44 | 5483.40 | 5141.90 | 6.64 |
| PBT | 5765.30 | 1449.60 | 297.72 | 5765.30 | 1449.60 | 297.72 | 5271.40 | -1615.30 | -426.34 |
| TAX | 995.70 | 277.80 | 258.42 | 995.70 | 277.80 | 258.42 | 1019.30 | 271.70 | 275.16 |
| Deferred Tax | -11.50 | -11.60 | -0.86 | -11.50 | -11.60 | -0.86 | 60.40 | -306.30 | -119.72 |
| PAT | 4769.60 | 1171.80 | 307.03 | 4769.60 | 1171.80 | 307.03 | 4252.10 | -1887.00 | -325.34 |
| Equity | 910.20 | 909.30 | 0.10 | 910.20 | 909.30 | 0.10 | 910.00 | 909.00 | 0.11 |
| PBIDTM(%) | 20.96 | 10.80 | 94.05 | 20.96 | 10.80 | 94.05 | 10.43 | 3.62 | 188.03 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: